A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/395 (2006.01) A61K 31/396 (2006.01) A61K 31/415 (2006.01) A61K 31/4178 (2006.01) A61K 31/535 (2006.01) A61K 31/5377 (2006.01) C07D 203/08 (2006.01) C07D 203/14 (2006.01) C07D 403/12 (2006.01) C07D 521/00 (2006.01)
Patent
CA 2342943
A range of aziridin-1-yl nitrobenzamides (A-C) are provided for use as prodrugs in conjunction with nitroreductase (NR) enzymes. The amides may have 1 or 2 N-substituents which may be bulky and polar. For example, 5-(aziridin-1- yl) -N-[2-(4-morpholino) ethyl] -2,4-dinitrobenzamide of Compound (1) was found to be highly active against all NR+ cell lines tested.
L'invention porte sur une gamme d'aziridin-1-Yl nitrobenzamides utilisés comme prodrogues en association avec des enzymes du type nitroréductase (NR). Lesdits amides peuvent comporter 1 ou 2 substituants massifs ou polaires. Il peut par exemple s'agir du 5-(aziridin-1-Yl) N-[2-(4-morpholino)éthyl] -2,4-dinitrobenzamide du composant (1) qui s'est avéré très actif contre toutes les lignées de cellules NR+ testées.
Atwell Graham John
Denny William Alexander
Palmer Brian Desmond
Wilson William Robert
Auckland Uniservices Limited
Cancer Research Campaign Technology Limited
Kirby Eades Gale Baker
LandOfFree
Novel nitrophenylaziridine compounds and their use as prodrugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel nitrophenylaziridine compounds and their use as prodrugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel nitrophenylaziridine compounds and their use as prodrugs will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1393140